IBM aims to surpass the goal of the $1000 sequenced genome, ultimately bringing the cost to as low as $100, making a personal genome cheaper than a ticket to a Broadway play.
© 2009 Alvin Ziegler | All Rights Reserved
Subscribe to our RSS Feed.
Contact Alvin: Email | Twitter
Gridlock explores a clash of cutting-edge, Internet-based medicine with corporate dominance-forces which are quietly battling with real consequences for us all.